#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18126	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2467	899.8	0	.	n	.	0	G1207A	SNP	1207	1207	G	1612	1612	A	1139	A,T,C,G	1134,1,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18126	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2467	899.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1855	1855	T	1190	T,C,G	1182,7,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18126	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2467	899.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1589	1589	C	1124	C,T	1123,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31382	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4028	970.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1862	1862	A	1309	A,C,G	1306,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31382	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4028	970.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2496	2496	C	1094	C,T,A	1090,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31382	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4028	970.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2570	2570	A	1010	A,C	1009,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31382	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4028	970.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3122	3122	C	1099	C,T,A,G	1093,2,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31382	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4028	970.7	0	HET	.	.	.	G2351A,T	.	2351	2351	G	2876	2876	G	1127	G,A,T	852,274,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2526	folP	852	852	99.77	folP.l15.c4.ctg.1	2100	150.0	0	.	p	.	0	D71H	NONSYN	211	213	GAT	865	867	CAT	256;254;255	C,T,G,A;A;T	253,1,1,1;254;255	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2526	folP	852	852	99.77	folP.l15.c4.ctg.1	2100	150.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1264	1266	GTA	227;227;225	G;T;A	227;227;225	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2526	folP	852	852	99.77	folP.l15.c4.ctg.1	2100	150.0	1	SNP	p	R228S	0	.	.	682	684	CGC	1336	1338	CGC	212;216;214	C,G;G,T,A;C	211,1;214,1,1;214	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6674	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3890	213.5	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1268	1270	ATA	263;262;262	A;T;A	263;261;262	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6674	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3890	213.5	1	SNP	p	S91F	0	.	.	271	273	TCC	791	793	TCC	235;235;237	T;C,A;C,A	235;234,1;236,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6674	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3890	213.5	1	SNP	p	D95N	0	.	.	283	285	GAC	803	805	GAC	246;249;250	G,C,A;A;C	243,2,1;249;250	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6674	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3890	213.5	1	SNP	p	D95G	0	.	.	283	285	GAC	803	805	GAC	246;249;250	G,C,A;A;C	243,2,1;249;250	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	16	2272	mtrR	633	536	100.0	mtrR.l15.c4.ctg.1	1624	174.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1416	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1492	118.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1671	1673	GTC	282;286;280	G;T;C	282;286;280	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1824	1826	GCA	286;292;293	G,C;C,A;A,G	285,1;291,1;291,2	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2307	2309	ATT	285;286;283	A;T,C;T,C	285;285,1;282,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	1	SNP	p	D86N	0	.	.	256	258	GAC	777	779	GAC	280;280;281	G;A,C;C	280;279,1;281	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	1	SNP	p	S87W	0	.	.	259	261	AGT	780	782	AGT	280;280;282	A;G;T,C	280;280;280,2	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	1	SNP	p	S87R	0	.	.	259	261	AGT	780	782	AGT	280;280;282	A;G;T,C	280;280;280,2	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	1	SNP	p	S87I	0	.	.	259	261	AGT	780	782	AGT	280;280;282	A;G;T,C	280;280;280,2	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	6166	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3510	218.6	1	SNP	p	S88P	0	.	.	262	264	TCC	783	785	TCC	284;284;284	T,G;C,T,G;C	282,2;282,1,1;284	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5474	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3103	219.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1784	1786	GGC	315;314;308	G;G,T;C	315;312,2;308	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1526	1528	GCA	283;284;289	G,C;C;A,G	282,1;284;288,1	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1529	1531	ATC	289;288;290	A;T,A;C,A	289;287,1;288,2	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1541	1543	GTG	289;293;292	G;T,A;G	289;292,1;292	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1541	1543	GTG	289;293;292	G;T,A;G	289;292,1;292	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2045	2047	ACC	300;304;304	A;C;C,G	300;304;302,2	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2099	2101	GCG	300;296;295	G,C;C;G,T	298,1;296;294,1	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2099	2101	GCG	300;296;295	G,C;C;G,T	298,1;296;294,1	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2222	2224	GGC	316;316;316	G;G,C,A;C	316;314,1,1;316	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2231	2233	GGC	321;321;321	G,T;G;C,G	320,1;321;320,1	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	5238	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2922	223.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2249	2251	CCG	315;316;314	C,A;C,T;G	314,1;315,1;314	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	7312	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3557	255.8	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1828	1830	CTG	300;299;298	C,T;T,C;G,C	299,1;298,1;297,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3174	porA	1146	1146	99.83	porA.l6.c30.ctg.1	2361	167.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	840	840	C	232	C	232	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	T18M	NONSYN	52	54	ACG	582	584	ATG	294;291;294	A;T,G;G,T	294;290,1;293,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	957	959	CAA	302;305;301	C;A;A,C	302;305;300,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1164	1166	GAT	288;286;287	G,T;A;T	287,1;286;287	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1167	1169	GAT	287;287;284	G;A,C;T	287;286,1;284	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	V215T	NONSYN	643	645	GTT	1173	1175	ACT	278;279;278	A,T;C;T	277,1;278;277	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	I218T	NONSYN	652	654	ATC	1182	1184	ACC	280;282;284	A,T,G;C,A;C,G	277,1,1;281,1;283,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1299	1301	ATG	347;348;349	A;T,C;G,C	347;347,1;348,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1302	1304	AGC	348;346;342	A,T;G;C	347,1;346;342	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1305	1307	GGT	339;339;341	G,C;G;T,A,G	338,1;339;339,1,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1419	1421	AAC	306;307;306	A;A;C	306;307;306	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3678	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1855	245.7	1	SNP	p	G120K	0	.	.	358	360	GGC	888	890	GGC	289;289;294	G;G;C	289;289;294	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12676	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5279	299.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2204	2206	CAT	341;338;338	C,G,A;A;T	338,1,1;338;338	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1742	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1620	134.1	1	SNP	p	V57M	0	.	.	169	171	GTG	881	883	GTG	308;307;305	G;T,A;G	308;306,1;305	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
